Results: 3610

Do proximal and distal gastric tumours behave differently?

ABCD (São Paulo, Impr.); 29 (4), 2016
ABSTRACT Background: Although the incidence of gastric (adenocarcinoma) cancer has been decreasing over time, it is still one of the most common malignancies worldwide, and proximal tumours tend to have a worse prognosis. Aim: To compare surgical outcomes and prognosis between proximal - excluding tu...

Liver transplantation for carcinoma hepatocellular in Aão Paulo: 414 cases by the Milan/Brazil criteria

ABCD (São Paulo, Impr.); 29 (4), 2016
ABSTRACT Background: The criterion of Milan (CM) has been used as standard for indication of liver transplantation (LTx) for hepatocellular carcinoma (HCC) worldwide for nearly 20 years. Several centers have adopted criteria expanded in order to increase the number of patients eligible to liver transpl...

Principais causas da mortalidade masculina e os anos potenciais de vida perdidos por estes agravos

Ciênc. cuid. saúde; 15 (4), 2016
RESUMO Esta pesquisa teve como objetivo descrever o perfil da mortalidade masculina de Cuiabá-MT entre os anos de 2002-2012 segundo as principais causas de mortalidade masculina e os anos potenciais de vida perdidos (APVP) por esta população. Trata-se de um estudo ecológico, realizado a partir de 5.1...

Aumento de la mortalidad infantil en niños con síndrome de Down: Chile 1997-2013

Rev. méd. Chile; 144 (11), 2016
Background: Down syndrome (DS) is associated with higher child mortality especially due to cardiac malformations. Aim: To describe the trend in Chilean infant mortality in DS in the period 1997-2013 as compared to the general population without DS. Material and Methods: Raw data on infant deaths were ext...

Determinantes sociales de la edad de fallecimiento por causa cardiovascular

Rev. méd. Chile; 144 (11), 2016
Background: The association of cardiovascular diseases with socio-demographic factors has not been fully explored. Aim: To analyze the association of socio-demographic features with the survival time of individuals who died due to cardiovascular diseases. Material and Methods: The death registries publis...

Performance of adjuvant treatment correlates with survival in reoperated glioblastomas

Arq. neuropsiquiatr; 74 (11), 2016
ABSTRACT Objective To analyze cases of recurrent glioblastoma subjected to reoperation at a Brazilian public healthcare service. Methods A total of 39 patients subjected to reoperation for recurrent glioblastoma at the Department of Neurosurgery, São Paulo Hospital, Federal University of São Paulo,...

Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors

Summary Introduction: Breast cancer is the most cause of death, and approximately 90% of these deaths are due to metastases. Matrix metalloproteinase-2 (MMP-2) gelatinase activity is able to degrade a major constituent of the tumor microenvironment, type IV collagen. Two well-established proteins used a...

La mortalidad por cáncer en la Ciudad de Buenos Aires en el siglo XXI

En 2014, en la Argentina los tumores constituyeron la primera causa de muerte en los grupos de edad de 45 a 54 años y de 55 a 64 años, la segunda −después de las causas externas− para las edades comprendidas entre los 5 y 44 años, y la tercera en la población de 65 años y más −detrás de las...

Empirical antimicrobial therapy for late-onset sepsis in a neonatal unit with high prevalence of coagulase-negative Staphylococcus

J. pediatr. (Rio J.); 92 (5), 2016
Abstract Objective: The aim of this study was to compare two different empiric treatments for late-onset neonatal sepsis, vancomycin and oxacillin, in a neonatal intensive care unit with a high prevalence of coagulase-negative Staphylococcus. Methods: A cross-sectional study was conducted in an neonata...

Chemotherapy for advanced non-small cell lung cancer in the elderly population

Säo Paulo med. j; 134 (5), 2016
ABSTRACT BACKGROUND: Approximately 50% of patients with newly diagnosed non-small cell lung cancer (NSCLC) are over 70 years of age at diagnosis. Despite this fact, these patients are underrepresented in randomized controlled trials (RCTs). As a consequence, the most appropriate regimens for these pati...